Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Etelcalcetide: What we know eight years since its approval
Pedro Freitas; Luciano Pereira;
Nefrologia (English Version). 2025;45:116-34
Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;
Nefrologia (English Version). 2023;43:197-203
Hyporesponsiveness or resistance to the action of parathyroid hormone in chronic kidney disease
Jordi Bover; Carolt Arana; Pablo Ureña; Armando Torres; Alejandro Martín-Malo; Leonor Fayos; Verónica Coll; María Jesús Lloret; Jackson Ochoa; Yolanda Almadén; Lluis Guirado; Mariano Rodríguez;
Nefrologia (English Version). 2021;41:514-28